{"title":"多发性硬化症的早期阶段:开发联合药物治疗的新目标","authors":"I. Cock, M. Cheesman","doi":"10.1088/978-0-7503-1762-7ch2","DOIUrl":null,"url":null,"abstract":"This chapter examines the bacterial triggers of rheumatoid arthritis and how they may induce self-reactive antibody production. In so doing, this report highlights some targets for drug treatments aimed at blocking the early phases of multiple sclerosis before the more serious later phase events occur.","PeriodicalId":127092,"journal":{"name":"Neurological Disorders and Imaging Physics, Volume 2","volume":"34 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"The early stages of multiple sclerosis: new targets for the development of combinational drug therapies\",\"authors\":\"I. Cock, M. Cheesman\",\"doi\":\"10.1088/978-0-7503-1762-7ch2\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"This chapter examines the bacterial triggers of rheumatoid arthritis and how they may induce self-reactive antibody production. In so doing, this report highlights some targets for drug treatments aimed at blocking the early phases of multiple sclerosis before the more serious later phase events occur.\",\"PeriodicalId\":127092,\"journal\":{\"name\":\"Neurological Disorders and Imaging Physics, Volume 2\",\"volume\":\"34 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neurological Disorders and Imaging Physics, Volume 2\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1088/978-0-7503-1762-7ch2\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurological Disorders and Imaging Physics, Volume 2","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1088/978-0-7503-1762-7ch2","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The early stages of multiple sclerosis: new targets for the development of combinational drug therapies
This chapter examines the bacterial triggers of rheumatoid arthritis and how they may induce self-reactive antibody production. In so doing, this report highlights some targets for drug treatments aimed at blocking the early phases of multiple sclerosis before the more serious later phase events occur.